Vaccination greatly reduces disease, disability, death and inequity worldwide.

In low-income countries, infectious diseases still account for a large proportion of deaths, highlighting health inequities largely caused by economic differences. Vaccination can cut health-care costs and reduce these inequities. Disease control, elimination or eradication can save billions of US dollars for communities and countries. Vaccines have lowered the incidence of hepatocellular carcinoma and will control cervical cancer. Travellers can be protected against "exotic" diseases by appropriate vaccination. Vaccines are considered indispensable against bioterrorism. They can combat resistance to antibiotics in some pathogens. Noncommunicable diseases, such as ischaemic heart disease, could also be reduced by influenza vaccination. Immunization programmes have improved the primary care infrastructure in developing countries, lowered mortality in childhood and empowered women to better plan their families, with consequent health, social and economic benefits. Vaccination helps economic growth everywhere, because of lower morbidity and mortality. The annual return on investment in vaccination has been calculated to be between 12% and 18%. Vaccination leads to increased life expectancy. Long healthy lives are now recognized as a prerequisite for wealth, and wealth promotes health. Vaccines are thus efficient tools to reduce disparities in wealth and inequities in health.

[1]  H. Maguire,et al.  Large outbreak of measles in London: reversal of health inequalities , 2005, Archives of Disease in Childhood.

[2]  J. Ehreth The global value of vaccination. , 2003, Vaccine.

[3]  T. Vesikari,et al.  Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. , 2006, The New England journal of medicine.

[4]  R. von Kries,et al.  Haemophilus influenzae type b disease: impact and effectiveness of diphtheria-tetanus toxoids-acellular pertussis (-inactivated poliovirus)/H. influenzae type b combination vaccines. , 2001, The Pediatric infectious disease journal.

[5]  J. Hedlund,et al.  Additive preventive effect of influenza and pneumococcal vaccines in elderly persons , 2004, European Respiratory Journal.

[6]  P. Rota,et al.  Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States. , 2006, The New England journal of medicine.

[7]  J. Goedert,et al.  The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa , 2004, Hepatology.

[8]  D. Sack,et al.  Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis , 2005, The Lancet.

[9]  R. Adegbola,et al.  Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study , 2005, The Lancet.

[10]  L. Moulton,et al.  Estimation of the indirect effect of Haemophilus influenzae type b conjugate vaccine in an American Indian population. , 2000, International journal of epidemiology.

[11]  F. André What can be done to make vaccines more trendy? , 2005, Expert review of vaccines.

[12]  L. Hessel,et al.  Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine. , 2003, Vaccine.

[13]  M. Miller,et al.  Policy analysis of the use of hepatitis B, Haemophilus influenzae type b-, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules. , 2000, Health economics.

[14]  Adam Wagstaff,et al.  Poverty and health sector inequalities. , 2002, Bulletin of the World Health Organization.

[15]  R. May,et al.  Infectious Diseases of Humans: Dynamics and Control , 1991, Annals of Internal Medicine.

[16]  S. Plotkin,et al.  Mass Vaccination : Global Aspects - Progress and Obstacles , 2006 .

[17]  J. Stockman Impact of Childhood Vaccination on Racial Disparities in Invasive Streptococcus pneumoniae Infections , 2006 .

[18]  M Elizabeth Halloran,et al.  Effects of pertussis vaccination on disease: vaccine efficacy in reducing clinical severity. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  R. Steffen,et al.  Vaccination priorities. , 2003, International journal of antimicrobial agents.

[20]  C. Macintyre,et al.  Immunization myths and realities: Responding to arguments against immunization , 2003, Journal of paediatrics and child health.

[21]  J. Lieberman Appropriate antibiotic use and why it is important: the challenges of bacterial resistance , 2003, The Pediatric infectious disease journal.

[22]  A. B. CiusnE,et al.  Typhoid fever. , 1967, The Journal of the Arkansas Medical Society.

[23]  Fletcher T Djelantik IG,et al.  WHO Position Paper on Haemophilus influenzae Vaccines , 2006 .

[24]  Reuben Samuel,et al.  Herd immunity and herd effect: new insights and definitions , 2004, European Journal of Epidemiology.

[25]  L. Pirofski,et al.  Vaccines for the prevention of diseases caused by potential bioweapons. , 2004, Clinical immunology.

[26]  A. Wilder-Smith,et al.  Sustained outbreak of W135 meningococcal disease in east London, UK , 2002, The Lancet.

[27]  M. Gahr,et al.  Efficacy of acellular pertussis vaccine in early childhood after household exposure. , 1996, JAMA.

[28]  O. Heinonen,et al.  Mumps and rubella eliminated from Finland. , 2000, JAMA.

[29]  A. Siitonen,et al.  Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine , 1991, The Lancet.

[30]  P. van Damme,et al.  Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory. , 2000, Vaccine.

[31]  A. Shearley,et al.  The societal value of vaccination in developing countries. , 1999, Vaccine.

[32]  Ziad A Memish,et al.  Health risks at the Hajj , 2006, The Lancet.

[33]  S. Gatchalian,et al.  Facilitating the WHO expanded program of immunization: the clinical profile of a combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine. , 2003, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[34]  N. Walker,et al.  Neonatal survival: a call for action , 2005, The Lancet.

[35]  P. Kaye Infectious diseases of humans: Dynamics and control , 1993 .

[36]  D. Bishai,et al.  Measles vaccination improves the equity of health outcomes: evidence from Bangladesh. , 2003, Health economics.

[37]  D. Henderson,et al.  Lessons from the eradication campaigns. , 1999, Vaccine.

[38]  Mei-Hwei Chang,et al.  Decreasing incidence of hepatocellular carcinoma among children following universal hepatitis B immunization , 2003, Liver international : official journal of the International Association for the Study of the Liver.

[39]  Robert T. Chen,et al.  Morbidity and Mortality Weekly Report , 2002 .

[40]  P. Kunasol,et al.  Protection against hepatitis A by an inactivated vaccine. , 1994, JAMA.

[41]  R. Succi,et al.  Vaccination in special situations. , 2006, Jornal de pediatria.

[42]  Impact of vaccines universally recommended for children--United States, 1990-1999. , 1999, Canada communicable disease report = Releve des maladies transmissibles au Canada.

[43]  W. Schaffner,et al.  Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. , 2006, The New England journal of medicine.

[44]  S. Schrag,et al.  Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. , 2004, JAMA.

[45]  J. Hanna,et al.  Impact of hepatitis A vaccination of Indigenous children on notifications of hepatitis A in north Queensland , 2004, The Medical journal of Australia.

[46]  M. Halloran,et al.  Cost-effectiveness of a routine varicella vaccination program for US children. , 1994, JAMA.

[47]  S. Ellenberg,et al.  A global perspective on vaccine safety and public health: the Global Advisory Committee on Vaccine Safety. , 2004, American journal of public health.

[48]  E. Shapiro,et al.  Effectiveness over time of varicella vaccine. , 2004, JAMA.

[49]  John Mullooly,et al.  Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. , 2003, The New England journal of medicine.

[50]  S. Hadler,et al.  Measles Herd Immunity: The Association of Attack Rates With Immunization Rates in Preschool Children , 1992 .

[51]  D. Canning,et al.  The Value of Vaccination , 1897, British medical journal.

[52]  M. Decker Principles of pediatric combination vaccines and practical issues related to use in clinical practice , 2001, The Pediatric infectious disease journal.

[53]  Q. Mok,et al.  Severe and unrecognised: pertussis in UK infants , 2003, Archives of disease in childhood.

[54]  D. Gertig,et al.  Lombok Hepatitis B Model Immunization Project: toward universal infant hepatitis B immunization in Indonesia. , 1995, The Journal of infectious diseases.

[55]  T. Scott,et al.  Measles vaccine , 2018, Reactions Weekly.

[56]  F. André Universal mass vaccination against hepatitis A. , 2006, Current topics in microbiology and immunology.

[57]  C. Wheeler,et al.  Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial , 2006, The Lancet.

[58]  A. Fiore,et al.  Hepatitis A transmitted by food. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[59]  P. Fine,et al.  Global poliomyelitis eradication: status and implications , 2007, The Lancet.

[60]  S. Obaro,et al.  Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial , 2005, The Lancet.

[61]  P. Hotez Vaccines as instruments of foreign policy , 2001, EMBO reports.

[62]  Antonio Boccia,et al.  The Efficacy of Influenza Vaccine for Healthy Children: A Meta-Analysis Evaluating Potential Sources of Variation in Efficacy Estimates Including Study Quality , 2007, The Pediatric infectious disease journal.

[63]  I. Chabot,et al.  The societal value of universal childhood vaccination. , 2004, Vaccine.

[64]  J. Best,et al.  Reducing global disease burden of measles and rubella: report of the WHO Steering Committee on research related to measles and rubella vaccines and vaccination, 2005. , 2007, Vaccine.